The two diseases with the highest avoidable noncompliance costs are hypercholesterolemia $44 billion and diabetes $24.6 billion, the study found.
via Patients average only C+ on drug compliance – amednews.com.
The two diseases with the highest avoidable noncompliance costs are hypercholesterolemia $44 billion and diabetes $24.6 billion, the study found.
via Patients average only C+ on drug compliance – amednews.com.